Avidity Partners Management LP Bausch Health Companies Inc. Transaction History

Avidity Partners Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $1.23 Million - $1.89 Million	215,100 New	215,100 $1.72 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $12 Million - $40 Million	-1,694,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $36.6 Million - $47.1 Million	1,694,700 New	1,694,700 $38.7 Million
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $51.9 Million - $61.8 Million	-1,891,300 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $1.72 Million - $2.77 Million	-80,700 Reduced 4.09%	1,891,300 $60 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $30.2 Million - $41.6 Million	1,972,000 New	1,972,000 $41 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.